Loading clinical trials...
Loading clinical trials...
A Feasibility Study Examining the Use of Non-Invasive Focused Ultrasound (FUS) With Oral Etoposide Administration in Children With Progressive Diffuse Midline Glioma (DMG)
Conditions
Interventions
Etoposide; Oral, 50 Mg
Focused ultrasound with neuro-navigator-controlled sonication
Locations
1
United States
Columbia University Irving Medical Center
New York, New York, United States
Start Date
June 5, 2023
Primary Completion Date
December 1, 2026
Completion Date
December 1, 2027
Last Updated
January 28, 2026
NCT05839379
NCT04943848
NCT04870944
NCT05077735
NCT05259605
NCT05956821
Lead Sponsor
Columbia University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions